The estimated Net Worth of Karen A Holbrook is at least $395 Тысяча dollars as of 6 September 2017. Karen Holbrook owns over 1,059 units of Bio-Techne Corp stock worth over $67,170 and over the last 18 years Karen sold TECH stock worth over $328,042.
Karen has made over 6 trades of the Bio-Techne Corp stock since 2014, according to the Form 4 filled with the SEC. Most recently Karen sold 1,059 units of TECH stock worth $128,912 on 6 September 2017.
The largest trade Karen's ever made was exercising 5,000 units of Bio-Techne Corp stock on 25 May 2017 worth over $332,950. On average, Karen trades about 1,062 units every 75 days since 2007. As of 6 September 2017 Karen still owns at least 914 units of Bio-Techne Corp stock.
You can see the complete history of Karen Holbrook stock trades at the bottom of the page.
Karen's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Bio-Techne Corp have traded over $37,160,097 worth of Bio-Techne Corp stock and bought 4,361 units worth $454,370 . The most active insiders traders include Charles R. Kummeth, Rupert Vessey и John L Higgins. On average, Bio-Techne Corp executives and independent directors trade stock every 23 days with the average trade being worth of $964,850. The most recent stock trade was executed by Kim Kelderman on 29 August 2024, trading 1,492 units of TECH stock currently worth $99,919.
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.
Bio-Techne Corp executives and other stock owners filed with the SEC include: